Search
for

    Sort by

    Research 421–450 of 1000+

    1. Cedrol mitigates hepatic lipid accumulation and adipocyte hypertrophy induced by corticosteroids through the inhibition of glucocorticoid receptor activity Scientific Reports · 2025
    2. Clinical and biochemical changes during high-dose glucocorticoid therapy in patients with pemphigus vulgaris (a comparative study with endogenous hypercortisolism) Almanac of Clinical Medicine · 2026
    3. Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database 2025
    4. Prolactin: an emerging force along the cutaneous–endocrine axis Trends in Endocrinology and Metabolism · 2010 · 51 citations
    5. Polycystic Ovary Syndrome: Pathophysiology, Presentation and Treatment a Mini-Review Article Serbian Journal of Experimental and Clinical Research · 2021
    6. Early Onset Werner Syndrome Turkish Journal of Endocrinology and Metabolism · 2015
    7. The Effects of Induced Polycystic Ovary Syndrome in NAG-1 Transgenic Mice ScholarWorks (Central Washington University) · 2020
    8. Adult polycystic ovary syndrome begins in childhood Best Practice & Research Clinical Endocrinology & Metabolism · 2002 · 124 citations
    9. Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome Open Journal of Endocrine and Metabolic Diseases · 2017
    10. Atypical Progeroid Syndrome due to Heterozygous Missense LMNA Mutations 2009 · 115 citations
    11. [Studies on monilethrix]. PubMed · 1979 · 2 citations
    12. MEDICINAL PLANTS USED IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME (PCOD) ˜The œBioscan. · 2026
    13. Polycystic Ovary Syndrome: Clinical Presentation, Diagnostic Challenges, and Evolving Management Approaches International Journal for Research in Applied Science and Engineering Technology · 2026
    14. Skin lesions in polycystic ovary syndrome Aesthetic Cosmetology and Medicine · 2022
    15. 11 Treatment of hirsutism and acne with cyproterone acetate Clinics in Endocrinology and Metabolism · 1986 · 43 citations
    16. Polycystic ovary syndrome in adult women Medicina Clínica (english Edition) · 2019 · 13 citations
    17. Pharmacological management of polycystic ovary syndrome Australian Prescriber · 2024 · 9 citations
    18. [Zinc deficiency dermatoses. Etiology, clinical aspects and treatment]. PubMed · 1982 · 13 citations
    19. 098 Simvastatin decreases AA-associated inflammation through effects on isoprenoid metabolites Journal of Investigative Dermatology · 2019
    20. SCALP HAIR CHARACTERISTICS IN THE NEWBORN INFANT Advances in neonatal care · 2003 · 46 citations
    21. Clinical and Biochemical Characteristics in PCOS Women With Menstrual Abnormalities. PubMed · 2016 · 3 citations
    22. Cytochrome P450: A Target for Drug Development for Skin Diseases 2004 · 115 citations
    23. Clinical biochemistry of dihydrotestosterone Annals of Clinical Biochemistry · 2013 · 50 citations
    24. What every physician should know about polycystic ovary syndrome Dermatologic therapy · 2008 · 33 citations
    25. Androgenic effects of oral contraceptives: Implications for patient compliance The American Journal of Medicine · 1995 · 22 citations
    26. Polycystic ovary syndrome InnovAiT · 2016 · 2 citations
    27. Polycystic Ovary Syndrome and Inflammation ISGE series · 2021
    28. The leaves of Crataeva nurvala Buch-Ham. modulate locomotor and anxiety behaviors possibly through GABAergic system BMC Complementary and Alternative Medicine · 2018 · 16 citations
    29. Progesterone Promotes Anti-Anxiety/Depressant-like Behavior and Trophic Actions of BDNF in the Hippocampus of Female Nuclear Progesterone Receptor, but Not 5α-Reductase, Knockout Mice International Journal of Molecular Sciences · 2025 · 4 citations
    30. Diet in dermatology: Revisited Indian Journal of Dermatology, Venereology and Leprology · 2010 · 40 citations